chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Injection site pain; Injection site redness; Tiredness; Headache; Muscle pain; Chills; Joint pain; Fever; Feeling unwell; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 02Apr2021 at 00:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had history of allergies to sulfa-based antibiotics. Concomitant medication included tamsulosin (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Apr2021 at 13:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site redness, feeling unwell. The patient reported that the events lasted for 72 hours or so. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site redness, feeling unwell were resolved with lasting effects on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: Chills; Headache; Muscle pain; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the right arm on 05Apr2021 at 07:45 (at the age 51-years-old) as a single dose for COVID-19 immunisation. Medical history included alopecia areata. The patient had no known allergies to medications, food or other products. Concomitant medications included vitamins (CENTRUM SILVER), coffae arabica; phosphatidyl serine (NEURIVA BRAIN PERFORMANCE) and diphenhydramine hydrochloride (ZZZQUIL) all taken from an unknown date for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 15Mar2021 (at the age 51-years-old)  as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 00:00, the patient experienced chills, headache, muscle and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with DAYQUIL and ibuprofen. The clinical outcome of the events of chills, headache, muscle and joint pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea
Clinical narrative: Feeling dizzy; Feeling some weakness; Occasionally short of breath; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the left arm on 02Apr2021 at 14:00 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history included colon cancer in 2015 (treatment successful). The patient did not have any allergies to food, medications, or other products. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 23:00, the patient was feeling dizzy, feeling some weakness and occasionally short of breath. The first night the patient started feeling dizzy when laid down to go to sleep and felt dizzy all night, whenever the head was moved. This feeling has not gone away at night. The patient also felt it off and on during the day. Also, the patient has been felt some weakness, and occasionally short of breath. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events feeling dizzy, feeling some weakness and occasionally short of breath was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node on left side between shoulder and neck; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8734) via an unspecified route of administration in the left arm on 30Mar2021 at 07:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient did not receive any medication within two weeks of vaccination. The patient did not have any allergies to medication, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 03Mar2021 at 07:00(at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00, the patient experienced swollen lymph node on left side between shoulder and neck. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event swollen lymph node on left side between shoulder and neck was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Tingling in legs; Tingling in feet; Numbness in legs; Numbness in feet; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on an unspecified date in Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unspecified date in Mar2021, the patient experienced tingling and numbness in legs and feet nine days out. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tingling and numbness in legs and feet was not resolved at the time of the report.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Had and continue with left side of facefeeling fuzzy; Lightheaded and dizziness more than usual; extreme joint pain in joints that usually do not hurt; Diarrhea; Exhausted and so tired; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included hip replacement (need hip replacement), thyroid disorder, hand osteoarthritis, osteoarthritis knees, hips osteoarthritis, heart murmur, penicillin allergy, iodine allergy and drug allergy (theramosol allergy). Concomitant medications included CELEBREX, omeprazole (MANUFACTURER UNKNOWN), ropinirole (MANUFACTURER UNKNOWN) and SYNTHROID. The patient previously took Benadryl and experienced allergy (allergic to benadryl). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 06:30, the patient experienced extreme joint pain in joints that usually do not hurt, lightheaded and dizziness more than usual, diarrhea, exhausted and so tired, also had and continue with left side of face feeling fuzzy. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheaded and dizziness more than usual, extreme joint pain in joints that usually do not hurt, diarrhea and exhausted and so tired were recovered/resolved with sequelae on 21Mar2021. The clinical outcome of the event left side of face feeling fuzzy was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Vaccination site pain
Clinical narrative: Body aches; Arm soreness at the vaccination site; Extreme fatigue; Headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8735) via an unspecified route of administration in the left arm on 03Apr2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously received acetyl salicylic acid (ASPIRIN), ampicillin (MANUFACTURER UNKNOWN), nifedepine (MANUFACTURER UNKNOWN) and stone fruits (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), clarithromycin (CLARITIN) and budesonide (NASOCORT) all for unknown indication on an unknown date and unspecified medication for birth control on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced arm soreness at the vaccination site, extreme fatigue, headache and body aches. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events arm soreness at the vaccination site, extreme fatigue, headache and body aches were resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Dizziness
Clinical narrative: Felt like being in a fog; Dizziness; Very weak; Tiredness; Bad headache; Muscle pain; Chills; Fever from 100 to102.7 for 10 hours; Severe joint pain; Nausea; Swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 01Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and hypothyroidism. The patient had a history of allergy to sulfa. The patient had received medication within two weeks of vaccination which were unspecified. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 17:15 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:45, the patient experienced tiredness, bad headache, muscle pain, chills, fever from 100 to102.7 (units not specified) for 10 hours, severe joint pain, nausea, swollen lymph nodes, dizziness, very weak and felt like being in a fog. The symptoms went on for 72 hours and reported that 108 hours after the 2nd dose the patient still felt very tired and had a few aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tiredness, bad headache, muscle pain, chills, fever, severe joint pain, nausea, swollen lymph nodes, dizziness, very weak and felt like being in a fog was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Felt like being in a fog; Dizziness; Very weak; Tiredness; Bad headache; Muscle pain; Chills; Fever from 100 to102.7 for 10 hours; Severe joint pain; Nausea; Swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 01Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and hypothyroidism. The patient had a history of allergy to sulfa. The patient had received medication within two weeks of vaccination which were unspecified. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 17:15 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:45, the patient experienced tiredness, bad headache, muscle pain, chills, fever from 100 to102.7 (units not specified) for 10 hours, severe joint pain, nausea, swollen lymph nodes, dizziness, very weak and felt like being in a fog. The symptoms went on for 72 hours and reported that 108 hours after the 2nd dose the patient still felt very tired and had a few aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tiredness, bad headache, muscle pain, chills, fever, severe joint pain, nausea, swollen lymph nodes, dizziness, very weak and felt like being in a fog was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Felt like being in a fog; Dizziness; Very weak; Tiredness; Bad headache; Muscle pain; Chills; Fever from 100 to102.7 for 10 hours; Severe joint pain; Nausea; Swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 01Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and hypothyroidism. The patient had a history of allergy to sulfa. The patient had received medication within two weeks of vaccination which were unspecified. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 17:15 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:45, the patient experienced tiredness, bad headache, muscle pain, chills, fever from 100 to102.7 (units not specified) for 10 hours, severe joint pain, nausea, swollen lymph nodes, dizziness, very weak and felt like being in a fog. The symptoms went on for 72 hours and reported that 108 hours after the 2nd dose the patient still felt very tired and had a few aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tiredness, bad headache, muscle pain, chills, fever, severe joint pain, nausea, swollen lymph nodes, dizziness, very weak and felt like being in a fog was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Fatigue, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Sore arm; Fatigue; Slight elevated temperature (1 degree); Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 08:15 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history and did not have a history of allergies to food, medications, or other products. The patient received unspecified birth control medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. On 06Apr2021 at 12:00, the patient experienced sore arm, fatigue, chills and slightly elevated temperature (1 degree). The patient underwent lab tests and procedures which included nasal swab test on an unknown date and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events sore arm, fatigue, chills and elevated temperature was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain in extremity
Clinical narrative: Sore arm; Migraine; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included cetirizine (CETIRIZINE) taken for an unknown indication from an unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID -19 vaccination. On 06Apr2021 at 10:45, the patient experienced sore arm and migraine. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events sore arm and migraine was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia
Clinical narrative: Sleeplessness; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 18:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included NSAIDs allergy. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 20:00, the patient experienced headache and on 03Apr2021, the patient experienced sleeplessness. The patient did not receive any treatment for these events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event headache and sleeplessness were not recovered at the time of this report.   Follow up attempts are not possible; Information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Somnolence
Clinical narrative: Sored arm; flu-like symptoms  (chills, general body pain); flu-like symptoms  (chills, general body pain); tiredness; sleepy; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0151) via an unspecified route of administration in the right arm on 05Apr2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 05Apr2021 at 11:00, the patient had experienced sore arm, flu-like symptoms (chills and general body pain), tiredness and sleepy. Therapeutic measures were taken as a result of adverse events ad included Advil. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sored arm, flu-like symptoms (chills and general body pain), tiredness and sleepy was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER26B), via an unspecified route of administration in the right arm on 27Mar2021 at 11:15 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included severe penicillin allergy on an unknown date. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 01:30, the patient woke up with an extremely severe headache in the top front of head, that brought on severe vomiting for 20 minutes. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extremely severe headache in the top front of head and severe vomiting for 20 minutes were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Dry eye, Migraine, Pain, Vision blurred
Clinical narrative: Dry eyes; Small Migraine; Haziness; Soreness; This is a spontaneous report from a non-contactable pharmacist. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8131) via intramuscular route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no allergies to medications, food, or other products. Concomitant medications included amlodipine 10 with unspecified units (MANUFACTURER UNKNOWN), perindopril 8 with unspecified units (MANUFACTURER UNKNOWN) and finasteride 1 with unspecified units (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via intramuscular route of administration in the left arm on 09Mar2021 at 10:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 00:00, the patient experienced dry eyes, small migraine, haziness and soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of dry eyes, migraine, hazy vision and pain was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Erythema, Fatigue
Clinical narrative: Freezing; Sweating; Achy; Headache; Loss of appetite; Fatigued; Light-headed; Itchy red hands; Itchy red hands; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 11:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, ankylosing spondylitis, low thyroid and allergy to penicillin and sulfa. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), etanercept (ENBREL), vitamins (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received ampicillin (MANUFACTURER UNKNOWN), infliximab (INFLECTRA), erythromicin (MANUFACTURER UNKNOWN), amoxicillin (MANUFACTURER UNKNOWN) and tetracycline (MANUFACTURER UNKNOWN); all on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:00, the patient experienced freezing, sweating, achy, headache, loss of appetite, fatigued, light headed and itchy red hands. The patient stated that day 5 after injection was the worse so far. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events freezing, sweating, achy, headache, loss of appetite, fatigued, light headed and itchy red hands was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Pain, Pruritus
Clinical narrative: Freezing; Sweating; Achy; Headache; Loss of appetite; Fatigued; Light-headed; Itchy red hands; Itchy red hands; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 11:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, ankylosing spondylitis, low thyroid and allergy to penicillin and sulfa. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), etanercept (ENBREL), vitamins (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received ampicillin (MANUFACTURER UNKNOWN), infliximab (INFLECTRA), erythromicin (MANUFACTURER UNKNOWN), amoxicillin (MANUFACTURER UNKNOWN) and tetracycline (MANUFACTURER UNKNOWN); all on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:00, the patient experienced freezing, sweating, achy, headache, loss of appetite, fatigued, light headed and itchy red hands. The patient stated that day 5 after injection was the worse so far. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events freezing, sweating, achy, headache, loss of appetite, fatigued, light headed and itchy red hands was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Phlebitis
Clinical narrative: phlebitis; This is a spontaneous report from a contactable consumer reported for herself. A 36-year-old female patient (will be 37 next week) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/lot number: EN6207, Expiration date: Unknown), via an unspecified route on 23Mar2021 (age at vaccination: 36-year-old), as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, patient experienced bursts of blood vessels. One of her veins down my arm inner arm, elbow was all bruised swollen and painful, reaction it was categorized as: phlebitis. Patient asked if they recommend for the 2nd dose. Therapeutic measures taken as a result of the events included Medrol dose. She has not yet, but they have just prescribed her with Medrol dose. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (Solution injection; Batch/Lot Number: EN6201), via an unspecified route of administration on 18Feb2021 single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced a sore arm but nothing else. Patient reported that several people had asked if this could have been a reaction to the vaccine. The outcome of the event unknown.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site irritation, Vaccination site mass, Vaccination site pain
Clinical narrative: less raised but oddly hot and itchy; less raised but oddly hot and itchy; less raised but oddly hot and itchy; the injection site became red and swollen (half dollar size); fatigued; the injection site became red and swollen (half dollar size); the injection site became red and swollen (half dollar size); This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 21Apr2021 as (At the age of 49-years) DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that a 49-years-old female patient received her 2nd PFE covid vaccine yesterday. On 22Apr2021 patient experienced in the morning the injection site became red and swollen (half dollar size) and she had fatigued, On 24Apr2021 less raised but oddly hot and itchy. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: less raised but oddly hot and itchy; less raised but oddly hot and itchy; less raised but oddly hot and itchy; the injection site became red and swollen (half dollar size); fatigued; the injection site became red and swollen (half dollar size); the injection site became red and swollen (half dollar size); This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 21Apr2021 as (At the age of 49-years) DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that a 49-years-old female patient received her 2nd PFE covid vaccine yesterday. On 22Apr2021 patient experienced in the morning the injection site became red and swollen (half dollar size) and she had fatigued, On 24Apr2021 less raised but oddly hot and itchy. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Illness, Nausea, Pain in extremity
Clinical narrative: Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; This is a spontaneous report from a contactable consumer.  A 61-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 61-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date after first dose,, the patient experienced got sick the night got the vaccine. sore arm, nauseaous, couldn't breathe, didn't want to move. The outcome of the events were unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Mass, Pain
Clinical narrative: Her neck was getting inflamed; Has her neck inflamed on the left side of her neck, on the side where the shot was given; She has a ball on her collarbone like a tiny ball and when she touches, it hurts; She has a ball on her collarbone like a tiny ball; This is a spontaneous report from a contactable consumer (patient's Daughter). A 49-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Lot Number: ER8731), via an unspecified route of administration on an unspecified date into Arm Left as a single dose for COVID-19 immunisation. Medical history included thyroid disorder from an unknown date and unknown if ongoing Verbatim: Thyroid. Concomitant medication(s) included hydroxyzine, levothyroxine. On an unspecified date, the patient had a ball on her collarbone like a tiny ball and when she touches, it hurts and she also has her neck inflamed on the left side of her neck, on the side where the shot was given, the shot was given on her arm, but her arm is okay. Her mother received the first dose of Pfizer-BioNTech COVID-19 Vaccine and they reported that her neck was getting inflamed and described it as a little ball on top of her collarbone. So, I have provided the information to the caller with regards to what to do about the side effects and to reach out to their doctor or healthcare professional. Reporter stated that She got the ball on Saturday and the information yesterday. She didn't get any information; she was just given a paper on the site and it said for those who wanted to know the side effect of having neck getting inflamed to go ahead and call. We don't know who the doctor was we just know that it was in a complex. No name was given like we don't know the information who gave the vaccine, what doctors were there, we know that it was in a complex and there were a bunch of tables where they were administrating the vaccine. It was 'hererson/pureous fort complex' (not clarified). She did not have the schedule for the second dose, they are going to let us know. She was just mainly worried about her neck and what to do about that. Reason of delay: Daily spike of incoming calls due to COVID19 vaccine. The patient did not receive any treatment for the events. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling, Swelling of eyelid, Swollen tongue, Urticaria
Clinical narrative: Right eyelid swelled up; Tongue swelled up on the bottom left side; quarter-sized hives on my left arm, thighs and back; Occasional eye swelling; This is a spontaneous report from a contactable consumer (patient). A 58-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, administered in left arm on 22Apr2021 10:15 (at the age of 58 years old) as dose 2, single for covid-19 immunization. There were no medical history and concomitant medications. The patient had no covid prior vaccination. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive other medications within 2 weeks of vaccination. The patient received the first dose of BNT162B2 on 24Mar2021 at 11:30 AM for Covid-19 Immunization administered at the left arm at the age of 58 years old. The most recent COVID-19 vaccine was administered at a pharmacy or drug store. It was reported that on 24Apr2021 at 06:00 PM (18:00), also reported as 48 hours after 2nd dose, patient tongue swelled up on the bottom left side and patient broke up quarter-sized hives on my left arm, thighs and back. Four days after dosage, 26Apr2021, his right eyelid swelled up. Patient was reported to still consistently experiencing large hive breakouts throughout body and occasional eye swelling a week after dosage (Apr2021). The events were reported as medically significant. There were no treatments received in response to the events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Electrocardiogram, Heart rate, Hypertension, Palpitations
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia, SARS-CoV-2 test, Vision blurred, Visual impairment, Vitreous floaters
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal sensation in eye, Asthenia, Blood pressure increased, Blood test, Cardiac monitoring
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.